Cases prostate cancer are on the rise in California, according to new research.
The UC San Francisco (UCSF) study included nearly 388,000 men who had prostate cancer between 2004 and 2021.
The incidence rate in cases increased by 6.7% a year on average between 2011 and 2021, the research revealed the published pits.
The usual cancer type can be detected by a new blood test
Although cases increased, prostate cancer mortality rates decreased 2.6% annually from 2004 to 2012, and they were charged from 2012 to 2021. These trends were similar to age, races, ethnicity and region, researchers revealed.
In 2018, the US Working Group for Preventive Services began to recommend that men between the ages of 55 and 69 discuss “possible advantages and damage to their doctors,” the UCSF statement said.
Cases in the rise correspond to the change of guidelines for PSA (prostate specific antigen) testing, in which the US Working Group for Preventive Services (USPSTF) ceased to recommend projections in 2012, according to a statement by UCSF.
The guidelines have been changed to reduce the number of patients with prostate cancer who have been treated with “potentially harmful interventions” for not threatening forms of the disease.
It was expected that the deaths of men of men by 2050 would increase more than 90%,
According to UCSF, prostate cancer is The most common cancer Among men and other leading cause of cancer death.
Most prostate cancer tumors, however, are of low degree and “never spread”-and the PSA’s screen “does not differentiate aggressive or non-aggressive tumors, which led to many men to be diagnosed with cancer that would not hurt them in the long run,” the statement is specified.
Prostate cancer is the most common cancer among men and other leading cause of cancer death. (Andrew Harrer/Bloomberg via Getty Images)
“On the other hand, if the scalp is not done, a timely diagnosis more Advanced cancer It can be missed – these carcinomas could be successfully treated if they are early, “UCSF noted.
Unfortunately, freezing in examinations “may have led to one of the biggest subsequent increasing incidence of distant stadium disease,” according to researchers.
“If the screening is not done, a timely diagnosis of more advanced cancer can be missed.”
UCSF wrote that these findings “reinforce the need for a screening that can identify potentially fatal tumors without raising fake alarms about those who do not represent a threat to the patient.”
Increasing cases could be due to various factors, including obesity and increasing alcohol and fatty food consumption, according to a doctor who spoke with Fox News Digital. (East)
“Discovering the best way to display prostate cancer is still a challenge for researchers and doctors,” said the author of the leading study by Dr. Erin L. Van Blerigan, an associate professor of epidemiology, biostatistics and UCSF urology.
Click here to sign up for our Health Bulletin
“Without screening, the number of men who have been diagnosed with prostate cancer – when the treatments are less effective – it increases quickly.”
Senior medical analyst Fox News Dr. Marc Siegel, who was not involved in the studio, also called on the need for Regular projections.
For more health articles visit www.foxnews.com/health/health
“[Screenings] Reduced in many areas, including California, as the US Working Group for preventative services has recommended against a PSA as a regular tool for screening, which I do not always agree with, “he told Fox News Digital.” Especially since the MRI progressed, so not all elevated dogs automatically meant a biopsy. “
Based on the increase in prostate cancer cases in all age groups, Siegel emphasized the need to “diagnose early for better outcomes.”
“Without screening, the number of men diagnosed with advanced prostate cancer – when treatments are less effective – it increases quickly,” the researcher said.
Siegel suggested that the increase in cases could also be a consequence of a Different factorsIncluding an epidemic of obesity, ultra -frozen foods and increasing alcohol and fatty food consumption.
David R. Wise, MD, Urological Oncologist and Head of Service in the Genitourinary Medical Oncology Program program in the NYU Langone Perlmutter Cancer Center, also responded to this increase in cases.
“Return to prostate cancer screening is likely to reverse this effect.”
“The increasing incidence of prostate prostate metastatic cancer in California in 2010 is in line with reports of others, including the US Cancer Society,” said Wise, who was not involved in research, for Fox News Digital.
“This probably reflects the consequences of reduced prostate cancer. The return to the prostate cancer screening is likely to reverse that effect.”
Click here to get the Fox News app
“Optimized screening, improved MRI and new blood -based biomarkers, is now available and is ready to spare men with low risk of unnecessary treatment, while providing early detection of men with aggressive cancer,” he added.
